Assessment templates and guidance
The documents provide general guidance on the evaluation of the quality , non-clinical and clinical aspects of new drug applications and extension applications.
CHMP, CAT and (Co)Rapporteurs should circulate the assessment reports and comments via Eudralink.
Assessors should always submit assessment reports and comments for initial marketing authorisation applications to:
- the EMA product lead and product assistant (whose names are listed on the dashboard for national competent authorities);
- the product shared mailbox (whose format is always 'product name-product number' in one word, followed by '@ema.europa.eu');
- the product's dedicated initial MAA mailbox (whose format is always 'MAAproduct number' in one word, followed by '@ema.europa.eu').
The product number is always composed of 4 digits including xxxx if needed.
Assessors should have the Agency's styles installed in Microsoft Word to ensure optimal use of the templates.
For technical support with using the templates, please use EMA service desk .
To raise other queries or comments about the templates, please contact [email protected] .
Day 80 and Day 120 assessment report templates (containing guidance)
Day 80 assessment report - Quality template with guidance - Rev. 05. 21
English (EN) (143.11 KB - DOCX)
Annex 1 - Active substance master file (ASMF) assessment report template - Applicant's part rev. 07.18
English (EN) (34.73 KB - DOCX)
Annex 1 - Active substance master file (ASMF) assessment report template - Restricted part rev. 06.17
English (EN) (41.67 KB - DOCX)
Day 80 assessment report - Non-clinical template with guidance - Rev.10.23 Revamp
English (EN) (154.04 KB - DOCX)
Day 80 assessment report - Clinical template with guidance - Rev.04.24 Revamp
English (EN) (697.58 KB - DOCX)
Day 80 assessment report - New active substance status template - Rev. 03. 23
English (EN) (44.04 KB - DOCX)
Day 80 assessment report - Overview and D120 LOQ template with guidance - Rev. 10.23
English (EN) (233.58 KB - DOCX)
Peer reviewers comments at day 100
English (EN) (33.84 KB - DOCX)
- Note: instructions on how to delete green guidance text is in the cover page of the assessment report template.
Day 100 member states' and peer review comments
CHMP-CAT-PRAC member comments on rapporteur’s reports
English (EN) (32.03 KB - DOCX)
Day 150 or Day 195 joint assessment report templates and Day 180 CHMP list of outstanding issues
Day 150 or Day 195 joint assessment report - Quality template - Rev. 05. 21
English (EN) (34.15 KB - DOCX)
Day 150 or Day 195 joint response assessment report - Non-clinical template - Rev. 05. 21
English (EN) (32.02 KB - DOCX)
Day 150 or Day 195 joint response assessment report - Clinical template - Rev. 05. 21
English (EN) (35.22 KB - DOCX)
Day 150 or Day 195 joint response assessment report - Overview and list of outstanding issues template - Rev. 10.23
English (EN) (119.59 KB - DOCX)
Re-examination assessment report templates
(Co) Rapporteur (joint) assessment report of the grounds for the re-examination procedure - Rev. 05.21
English (EN) (45.5 KB - DOCX)
Informed consent assessment report template
Informed consent application in accordance with Article 10c of Directive 2001/83/EC - Rev. 05. 21
English (EN) (89.23 KB - DOCX)
Generic and hybrid medicinal products assessment report templates (containing guidance)
Generics - Hybrids - Day 80 assessment report - Quality template with guidance - Rev. 05. 21
English (EN) (78.78 KB - DOCX)
Generics - Hybrids - Day 80 assessment report - Non-clinical and clinical template with guidance - Rev. 05. 21
English (EN) (76.55 KB - DOCX)
Generics - Hybrids - Day 80 assessment report overview and D 120 list of outstanding issues template with guidance - Rev. 05. 21
English (EN) (132.5 KB - DOCX)
Generics - Hybrids - Day 150 or Day 195 joint report assessment report - Overview and D180 list of outstanding issues template with guidance - Rev. 05. 21
English (EN) (96.94 KB - DOCX)
Similarity assessment
CHMP and rapporteurs' joint assessment report on derogation applicable to similar orphan products - Rev. 03.23
English (EN) (140.49 KB - DOCX)
CHMP and Rapporteurs' assessment report template on Similarity Rev. 03.23
English (EN) (53.28 KB - DOCX)
Other templates
Certification evaluation report
English (EN) (210 KB - DOC)
Peer review of the certification procedure
English (EN) (126.5 KB - DOC)
CHMP/CAT member comments on rapporteurs’ reports
English (EN) (33.47 KB - DOCX)
- Assessment templates and guidance for an ancillary medicinal substance incorporated in a medical device
PRAC RMP assessment report template for initial marketing authorisation application and extension applications
PRAC D94 Rapporteur RMP assessment report template rev. 01.23
English (EN) (76.78 KB - DOCX)
Quick Response (QR) code
English (EN) (54 KB - DOC)
Companion diagnostics ('in-vitro diagnostics')
Consultation on companion diagnostic - Assessment report template
English (EN) (140.95 KB - DOCX)
For more information:
- Companion diagnostics ('in-vitro diagnostics')
Paediatric guidance
Structured guidance on the use of extrapolation
English (EN) (686.03 KB - PDF)
- Regulatory and procedural guidance
Share this page
European Medicines Agency ©1995-2024 | Disclaimer | For technical support, please visit the EMA Service Desk (ServiceNow) portal using your user credentials for a system hosted by EMA (except Eudravigilance). If you do not have an account or have forgotten your credentials, please click here
- No category
Template - European Medicines Agency
Related documents
Add this document to collection(s)
You can add this document to your study collection(s)
Add this document to saved
You can add this document to your saved list
Suggest us how to improve StudyLib
(For complaints, use another form )
Input it if you want to receive answer
IMAGES
COMMENTS
All companies submitting procedural information to the European Medicines Agency are reminded to insert the formatted table template in their cover letter. The formatted table template is used by companies when they submit information on a medicine to the Agency. It is intended to systematically structure and label the information provided.
Forms and templates; Forms and templates. Pre-submission interaction letter of intent form. Legal effective date: 22/04/2015 Reference Number: Version 1.0.4 Summary: ... European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands. Tel: +31 (0)88 781 6000.
The documents provide general guidance on the evaluation of the quality, non-clinical and clinical aspects of new drug applications and extension applications.. CHMP, CAT and (Co)Rapporteurs should circulate the assessment reports and comments via Eudralink.. Assessors should always submit assessment reports and comments for initial marketing authorisation applications to:
05 February 2016 Information Management Division, Version 4 Formatted table template To be inserted in each procedural submission cover letter. 1* Applicant/MAH Name 2* Customer Account Number 3* Customer Reference / Purchase 000060xxxx (only one number for WS and IG) Order Number 4 INN / Active substance 5 Product Name of centrally authorised medicinal product(s) 5.1* Nationally Authorised ...
Template for applicants to prepare report on similarity with authorised orphan medicinal products Template: Similarity report (September 2022) For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
A high-quality cover letter will facilitate validation and assessment. This also applies to the List of Changes to be submitted as a response to the RFI. Templates for transition trials can be found under section Guidance-Transitional trials. CTCG provides the following templates, to be used in different situations: Initial application cover ...
is submitting information in the enclosed table on paediatric study completed after 26 January 2007. Name of the medicinal product(s): ... Cover Letter Art 46 of Reg 1901/2006 <Product Name> Page 2/3. ... Last modified by: Johansson Tommy Created Date: 3/18/2015 11:34:00 AM Company: European Medicines Agency Other titles: EMA - Proposed update ...
Formatted Table Template implementation in the XML delivery files ... and after this it will be optional for applicants to provide the Formatted Template as a part of the Cover Letter in Module 1 of eCTD sequences or Part 1 of VNeeS dossier. ... All European Medicines Agency (EMA) information technology (IT) systems will be temporarily ...
Within the submission dossier table templates are provided up to section 5.1. Table templates for the following sections (Section 5.2 et seq.) are provided in a separate file with table ... EMA European Medicines Agency EU European Union HaDEA European Health and Digital Executive Agency HTA Health Technology Assessment HTAR Regulation (EU ...
Template - European Medicines Agency. advertisement ... The Table of Changes should be included as a separate document to the main Submission Cover Letter. The ASMF holder should use the following example templates for the table. If the changes have been previously authorised in a National or European procedure, the ASMF holder should annotate ...